Press releases 2004

Date		Headline
16/12/04		Oxford BioMedica Publishes Preclinical Efficacy Results with its Product Candidate SMN1-G for Spinal Muscular Atrophy
13/12/04		Oxford BioMedica Licenses Retroviral Ex Vivo Gene Delivery Technology to MolMed SpA
29/10/04		Oxford BioMedica and ARIUS Research Extend Collaboration on Novel Cancer Targets
17/09/04		Oxford BioMedica Signs License Agreement with Massachusetts General Hospital, Boston University and Dana-Farber Cancer Institute
01/09/04		Oxford BioMedica Plc Interim Results
01/09/04		Oxford BioMedica Announces Positive Interim Phase II Results with Trovax in Colorectal Cancer
24/08/04		Interim Results : Web Cast Notification Wednesday 1 September 2004
18/08/04		Appointment of Broker
05/07/04		Oxford BioMedica Licenses LentiVector^® Technology to Viragen for Avian Transgenics Biomanufacturing
30/06/04		Notice of Interim Results for the Six Months Ended 30 June 2004
21/06/04		Oxford BioMedica Publication - LentiVector^® Gene Delivery System Results in High Success Rate in Avian Transgenics Program
17/06/04		Oxford BioMedica - Innurex^® Programme
07/06/04		Oxford BioMedica Acquires Chiron Patents and Issues Shares to Chiron
02/06/04		Oxford BioMedica's Innurex^® Product Restores Limb Function in a Preclinical Model of Avulsion Injury